| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.0086 | 0.8 |